Simon Mucha

1.1k total citations
21 papers, 289 citations indexed

About

Simon Mucha is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Simon Mucha has authored 21 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Simon Mucha's work include COVID-19 Clinical Research Studies (5 papers), Cell death mechanisms and regulation (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Simon Mucha is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Cell death mechanisms and regulation (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Simon Mucha collaborates with scholars based in United States, Germany and France. Simon Mucha's co-authors include Enrico N. De Toni, Alexander L. Gerbes, Sören T. Eichhorst, Christian Kuntzen, Siddharth Dugar, Gretchen L. Sacha, John R. Bartholomew, Keith R. McCrae, Michael Militello and Peter Čamaj and has published in prestigious journals such as PLoS ONE, Cancer Research and Gut.

In The Last Decade

Simon Mucha

16 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Mucha United States 8 137 90 70 35 32 21 289
Ioannis P. Trontzas Greece 11 97 0.7× 153 1.7× 79 1.1× 36 1.0× 44 1.4× 32 338
Jieyu Ye China 14 190 1.4× 154 1.7× 96 1.4× 115 3.3× 36 1.1× 49 695
Sung‐Soo Yoon South Korea 12 85 0.6× 96 1.1× 22 0.3× 39 1.1× 14 0.4× 42 364
Grerk Sutamtewagul United States 9 66 0.5× 60 0.7× 84 1.2× 11 0.3× 44 1.4× 26 268
Rashid Khan United States 9 123 0.9× 79 0.9× 21 0.3× 12 0.3× 14 0.4× 23 291
Giuseppa Scandurra Italy 11 113 0.8× 243 2.7× 86 1.2× 34 1.0× 24 0.8× 47 498
Annika Kurreck Germany 7 40 0.3× 115 1.3× 64 0.9× 10 0.3× 30 0.9× 33 239
Laura Longo Italy 10 44 0.3× 42 0.5× 59 0.8× 31 0.9× 41 1.3× 27 377
Chisato Sato Japan 11 82 0.6× 64 0.7× 107 1.5× 9 0.3× 31 1.0× 30 363
Myke R. Green United States 11 81 0.6× 155 1.7× 48 0.7× 55 1.6× 43 1.3× 24 396

Countries citing papers authored by Simon Mucha

Since Specialization
Citations

This map shows the geographic impact of Simon Mucha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Mucha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Mucha more than expected).

Fields of papers citing papers by Simon Mucha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Mucha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Mucha. The network helps show where Simon Mucha may publish in the future.

Co-authorship network of co-authors of Simon Mucha

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Mucha. A scholar is included among the top collaborators of Simon Mucha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Mucha. Simon Mucha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mucha, Simon, et al.. (2024). RSV-MEDIATED HLH IN THE SETTING OF MULTIPLE MYELOMA: A DIAGNOSTIC AND THERAPEUTIC CONUNDRUM. CHEST Journal. 166(4). A2071–A2072.
2.
Duggal, Abhijit, R.G. Scheraga, Gretchen L. Sacha, et al.. (2024). Forecasting disease trajectories in critical illness: comparison of probabilistic dynamic systems to static models to predict patient status in the intensive care unit. BMJ Open. 14(2). e079243–e079243. 1 indexed citations
3.
Mucha, Simon, et al.. (2024). THE WARBURG EFFECT: UNEXPLAINED LACTIC ACIDOSIS AS INITIAL MANIFESTATION OF AGGRESSIVE LYMPHOMA. CHEST Journal. 166(4). A2252–A2253.
4.
Mucha, Simon & Prabalini Rajendram. (2023). Management and Prevention of Cellular-Therapy-Related Toxicity: Early and Late Complications. Current Oncology. 30(5). 5003–5023. 11 indexed citations
5.
Mireles‐Cabodevila, Eduardo, et al.. (2023). A Framework for Developing a Multidisciplinary Approach to Prone Positioning in Acute Respiratory Distress Syndrome. Journal of Intensive Care Medicine. 38(8). 702–709. 2 indexed citations
6.
Sato, Ryota, Siddharth Dugar, Xiaozhen Han, et al.. (2022). TIME FROM HOSPITAL ADMISSION TO ONSET OF SEPTIC SHOCK IS ASSOCIATED WITH HIGHER IN-HOSPITAL MORTALITY. Shock. 58(3). 211–216.
7.
Singh, Achintya D., Simon Mucha, & Christina C. Lindenmeyer. (2022). Cirrhotic coagulopathy: A rebalanced hemostasis. Cleveland Clinic Journal of Medicine. 89(9). 523–533. 8 indexed citations
8.
Mucha, Simon, et al.. (2022). 353: CYTOKINE RELEASE STORM FOLLOWING IMMUNE CHECKPOINT INHIBITOR USE MANAGED WITH TOCILIZUMAB IN THE ICU. Critical Care Medicine. 51(1). 162–162.
10.
Sato, Ryota, Ashish K. Khanna, Simon Mucha, Abhijit Duggal, & Siddharth Dugar. (2021). 1421: NOREPINEPHRINE EQUIVALENT DOSE IS STRONGLY ASSOCIATED WITH IN-HOSPITAL MORTALITY IN SEPTIC SHOCK. Critical Care Medicine. 50(1). 713–713. 1 indexed citations
11.
Mucha, Simon, et al.. (2021). 196: ENCEPHALOPATHY AFTER COVID-19 INFECTION AND VACCINE IN A PATIENT WITH UNDERLYING AUTOIMMUNE DISEASE. Critical Care Medicine. 50(1). 82–82. 1 indexed citations
12.
Mucha, Simon, Siddharth Dugar, Keith R. McCrae, et al.. (2020). Coagulopathy in COVID-19: Manifestations and management. Cleveland Clinic Journal of Medicine. 87(8). 461–468. 72 indexed citations
13.
Mucha, Simon, Siddharth Dugar, Keith R. McCrae, et al.. (2020). Update to coagulopathy in COVID-19: Manifestations and management. Cleveland Clinic Journal of Medicine. 5 indexed citations
14.
Mucha, Simon, et al.. (2020). Convalescent plasma for COVID-19: Promising, not proven. Cleveland Clinic Journal of Medicine. 87(11). 664–670. 5 indexed citations
15.
Goutaudier, Valentin, Hélène Perrochia, Simon Mucha, et al.. (2019). C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection. Frontiers in Immunology. 10. 235–235. 13 indexed citations
16.
Rubin, Sébastien, Simon Mucha, Robin Siadous, et al.. (2019). Towards an in vitro model of the glomerular barrier unit with an innovative bioassembly method. Nephrology Dialysis Transplantation. 35(2). 240–250. 6 indexed citations
17.
Rigothier, Claire, Sébastien Rubin, Simon Mucha, et al.. (2017). MP052PERFUSED GLOMERULAR MICROVASCULAR UNIT. A GLOMERULAR PATHOPHYSIOLOGY MODEL. Nephrology Dialysis Transplantation. 32(suppl_3). iii445–iii445.
18.
Mucha, Simon, Alexander L. Gerbes, Peter Čamaj, et al.. (2008). JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand. Gut. 58(5). 688–698. 52 indexed citations
19.
Toni, Enrico N. De, Christian Kuntzen, Alexander L. Gerbes, et al.. (2006). P60-c-src suppresses apoptosis through inhibition of caspase 8 activation in hepatoma cells, but not in primary hepatocytes. Journal of Hepatology. 46(4). 682–691. 20 indexed citations
20.
Kuntzen, Christian, et al.. (2005). Inhibition of c-Jun-N-terminal-Kinase Sensitizes Tumor Cells to CD95-Induced Apoptosis and Induces G2/M Cell Cycle Arrest. Cancer Research. 65(15). 6780–6788. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026